{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:44:40Z","timestamp":1762623880073,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.revmed.2017.01.013","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T19:45:42Z","timestamp":1495050342000},"page":"467-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prise en charge du risque h\u00e9morragique associ\u00e9 aux agents antiplaquettaires"],"prefix":"10.1016","volume":"38","author":[{"given":"A.-C.","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Houssany-Pissot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Zlotnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Godier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2017.01.013_bib0285","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2017.01.013_bib0290","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2017.01.013_bib0295","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"McQuaid","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2017.01.013_bib0300","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"Gent","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2017.01.013_bib0305","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2017.01.013_bib0310","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.CIR.0000091201.39590.CB","article-title":"Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the clopidogrel in unstable angina to prevent Recurrent Events (CURE) study","volume":"108","author":"Peters","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2017.01.013_bib0315","doi-asserted-by":"crossref","first-page":"e104402","DOI":"10.1371\/journal.pone.0104402","article-title":"Efficacy and safety of adding clopidogrel to aspirin on stroke prevention among high vascular risk patients: a meta-analysis of randomized controlled trials","volume":"9","author":"Chen","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.revmed.2017.01.013_bib0320","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2017.01.013_bib0325","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2017.01.013_bib0330","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2017.01.013_bib0335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1603060","article-title":"Ticagrelor versus aspirin in acute stroke or transient ischemic attack","volume":"375","author":"Johnston","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2017.01.013_bib0340","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2017.01.013_bib0345","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/CIRCULATIONAHA.107.694273","article-title":"Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?","volume":"116","author":"Spencer","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2017.01.013_bib0350","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2017.01.013_bib0355","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jacc.2015.06.1323","article-title":"Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention","volume":"66","author":"Genereux","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2017.01.013_bib0360","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehq021","article-title":"Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis","volume":"31","author":"Ducrocq","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.revmed.2017.01.013_bib0365","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.jacc.2009.09.076","article-title":"A risk score to predict bleeding in patients with acute coronary syndromes","volume":"55","author":"Mehran","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2017.01.013_bib0370","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2010.03.048","article-title":"Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window","volume":"56","author":"Sibbing","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2017.01.013_bib0375","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.amjcard.2010.11.025","volume":"107","author":"Patti","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.revmed.2017.01.013_bib0380","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.jcin.2015.08.032","article-title":"Is there an ideal level of platelet P2Y12-receptor inhibition in patients undergoing percutaneous coronary intervention? \u201cWindow\u201d analysis From the ADAPT-DES Study (assessment of dual antiplatelet therapy with drug-eluting stents)","volume":"8","author":"Kirtane","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.revmed.2017.01.013_bib0385","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2008.10.045","volume":"53","author":"Gurbel","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2017.01.013_bib0390","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1160\/TH15-02-0149","article-title":"Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome","volume":"114","author":"Bonello","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2017.01.013_bib0395","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1016\/j.ijcard.2013.04.052","article-title":"Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome","volume":"168","author":"Cuisset","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.revmed.2017.01.013_bib0400","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/eurheartj\/ehv104","article-title":"Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention","volume":"36","author":"Aradi","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.revmed.2017.01.013_bib0405","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/eurheartj\/eht375","article-title":"Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention","volume":"35","author":"Aradi","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.revmed.2017.01.013_bib0410","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(16)31323-X","article-title":"Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial","volume":"388","author":"Cayla","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2017.01.013_bib0415","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2017.01.013_bib0420","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"Prasugrel versus clopidogrel for acute coronary syndromes without revascularization","volume":"367","author":"Roe","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2017.01.013_bib0425","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2016.167","article-title":"Antiplatelet therapy: what have we learned from the ANTARCTIC trial?","volume":"13","author":"Gurbel","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.revmed.2017.01.013_bib0430","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1538-7836.2012.04641.x","article-title":"Reversal of the anti-platelet effects of aspirin and clopidogrel","volume":"10","author":"Li","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2017.01.013_bib0435","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/bja\/aet339","article-title":"Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor","volume":"112","author":"Hansson","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.revmed.2017.01.013_bib0440","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01586154-201305000-00027","article-title":"Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and\/or clopidogrel before emergency surgery?","volume":"74","author":"Taylor","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.revmed.2017.01.013_bib0445","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3171\/2012.9.JNS112286","article-title":"Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage","volume":"118","author":"Li","year":"2013","journal-title":"J Neurosurg"},{"key":"10.1016\/j.revmed.2017.01.013_bib0450","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/jth.12058","article-title":"Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation","volume":"11","author":"Zafar","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2017.01.013_bib0455","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/phar.1477","article-title":"Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety","volume":"34","author":"Dobesh","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.revmed.2017.01.013_bib0460","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s40265-013-0126-z","article-title":"Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties","volume":"73","author":"Ferri","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.revmed.2017.01.013_bib0465","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1538-7836.2011.04419.x","article-title":"Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses","volume":"9","author":"Storey","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2017.01.013_bib0470","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/EJA.0000000000000348","article-title":"The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: an in-vitro study","volume":"33","author":"Martin","year":"2016","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.revmed.2017.01.013_bib0475","doi-asserted-by":"crossref","first-page":"e002786","DOI":"10.1161\/CIRCINTERVENTIONS.115.002786","article-title":"Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study","volume":"8","author":"O\u2019Connor","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.revmed.2017.01.013_bib0480","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1056\/NEJMc1409373","article-title":"Inefficacy of platelet transfusion to reverse ticagrelor","volume":"372","author":"Godier","year":"2015","journal-title":"N Engl J Med"},{"year":"2015","series-title":"Recommandation de bonne pratique. Transfusion de plaquettes: produits, indications","author":"ANSM","key":"10.1016\/j.revmed.2017.01.013_bib0485"},{"key":"10.1016\/j.revmed.2017.01.013_bib0490","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/EJA.0b013e32835f4d5b","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology","volume":"30","author":"Kozek-Langenecker","year":"2013","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.revmed.2017.01.013_bib0495","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jcpt.12130","article-title":"The effect of desmopressin on bleeding time and platelet aggregation in healthy volunteers administered ticagrelor","volume":"39","author":"Teng","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.revmed.2017.01.013_bib0500","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1213\/XAA.0000000000000156","article-title":"Lack of effect of platelet transfusions and desmopressin on intracranial bleeding in a patient receiving ticagrelor","volume":"4","author":"Maillard","year":"2015","journal-title":"A A Case Rep"},{"year":"2015","series-title":"Brilique, summary of product characteristics","key":"10.1016\/j.revmed.2017.01.013_bib0505"},{"key":"10.1016\/j.revmed.2017.01.013_bib0510","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/EJA.0b013e32834050ab","article-title":"Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy","volume":"28","author":"Weber","year":"2011","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.revmed.2017.01.013_bib0515","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2003-07-2287","article-title":"Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generation","volume":"103","author":"Lisman","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2017.01.013_bib0520","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-9560-4-5","article-title":"Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis","volume":"4","author":"Altman","year":"2006","journal-title":"Thromb J"},{"key":"10.1016\/j.revmed.2017.01.013_bib0525","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2013.04.007","article-title":"In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel","volume":"132","author":"Mazzeffi","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.revmed.2017.01.013_bib0530","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/MBC.0000000000000511","article-title":"Boosting the coagulation restores haemostasis in ticagrelor-treated mice","volume":"8","author":"Pehrsson","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.revmed.2017.01.013_bib0535","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2015-01-622928","article-title":"Structural and functional characterization of a specific antidote for ticagrelor","volume":"125","author":"Buchanan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2017.01.013_bib0540","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/cc12685","article-title":"Management of bleeding and coagulopathy following major trauma: an updated European guideline","volume":"17","author":"Spahn","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.revmed.2017.01.013_bib0545","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gie.2015.09.035","article-title":"The management of antithrombotic agents for patients undergoing GI endoscopy","volume":"83","author":"Acosta","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.revmed.2017.01.013_bib0550","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cgh.2016.07.017","article-title":"No benefit from platelet transfusion for gastrointestinal bleeding in patients taking antiplatelet agents","volume":"15","author":"Zakko","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.revmed.2017.01.013_bib0555","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2017.01.013_bib0280","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/09537104.2015.1035247","article-title":"Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study","volume":"26","author":"Bonhomme","year":"2015","journal-title":"Platelets"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886631730036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886631730036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:37:44Z","timestamp":1759336664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S024886631730036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S024886631730036X"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2017.01.013","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge du risque h\u00e9morragique associ\u00e9 aux agents antiplaquettaires","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2017.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}